Aviva PLC lowered its stake in shares of PetMed Express, Inc. (NASDAQ:PETS – Get Rating) by 18.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,640 shares of the company’s stock after selling 17,201 shares during the quarter. Aviva PLC owned approximately 0.37% of PetMed Express worth $1,516,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. acquired a new stake in shares of PetMed Express in the 1st quarter worth about $288,000. US Bancorp DE increased its position in shares of PetMed Express by 319.1% during the 1st quarter. US Bancorp DE now owns 3,751 shares of the company’s stock valued at $97,000 after purchasing an additional 2,856 shares during the period. Bank of Montreal Can bought a new stake in shares of PetMed Express in the 1st quarter worth $236,000. MetLife Investment Management LLC lifted its holdings in shares of PetMed Express by 61.0% in the first quarter. MetLife Investment Management LLC now owns 10,376 shares of the company’s stock valued at $268,000 after buying an additional 3,930 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in PetMed Express by 14.3% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,086 shares of the company’s stock valued at $467,000 after buying an additional 2,257 shares in the last quarter. 77.74% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley dropped their price target on shares of PetMed Express from $19.00 to $18.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 8th.
PetMed Express Stock Performance
PetMed Express Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 27th. Shareholders of record on Monday, February 20th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.18%. The ex-dividend date of this dividend is Thursday, February 16th. PetMed Express’s payout ratio is 210.53%.
PetMed Express Company Profile
PetMed Express, Inc engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies.
Read More
- Get a free copy of the StockNews.com research report on PetMed Express (PETS)
- MarketBeat Week in Review – 2/20 – 2/24
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS – Get Rating).
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.
